Skip to main content

You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

OK Cancel

Back to top

Flyte Announces Strategic Partnership with The Nucleus Network to Support Inaugural Founders and Investors Event

Flyte partners with The Nucleus Network to support their inaugural event, enhancing collaboration within the entrepreneurial ecosystem.

Quiver AI Summary

Flyte, a subsidiary of Catheter Precision, Inc., has announced a strategic partnership with The Nucleus Network, which connects founders, investors, and innovators, to support the inaugural "The Nucleus" event on August 15, 2026. As an official partner, Flyte will participate in this premiere networking event, aiming to foster connections among approximately 200 attendees from the startup community. Flyte's CEO, Marc Sellouk, emphasized the company's commitment to building relationships within the entrepreneurial ecosystem. The partnership highlights Flyte's strategy to align with influential organizations and expand its presence in the private aviation market, where it operates a fleet of Cirrus Vision Jets and focuses on providing innovative and efficient travel experiences.

Potential Positives

  • Strategic partnership with The Nucleus Network positions Flyte as a key player in a prominent community of founders, investors, and operators, enhancing its industry visibility.
  • Participation in The Nucleus event allows Flyte to connect with approximately 200 influential figures in the entrepreneurial ecosystem, potentially leading to new business opportunities.
  • The partnership aligns with Flyte's strategy of forming relationships with influential organizations, reinforcing its commitment to innovation and collaboration within the private aviation sector.
  • Flyte's commitment to modernizing the private aviation experience through technology and strategic partnerships is highlighted, showcasing the company's growth and forward-thinking approach.

Potential Negatives

  • Partnership may highlight Flyte's need to align with external organizations to enhance its visibility and credibility within the competitive private aviation market.
  • Participation in The Nucleus event raises concerns about Flyte's current brand awareness and customer base, indicating it may not yet be a well-known name among target audiences.
  • The reliance on strategic partnerships for growth could signal a lack of independent strength or unique value propositions in Flyte's business model.

FAQ

What is the purpose of Flyte's partnership with The Nucleus Network?

The partnership aims to support the inaugural "The Nucleus" event, fostering connections among founders, investors, and innovators.

When and where is the inaugural "The Nucleus" event taking place?

The event is scheduled for August 15th at 4:00 p.m. at a location in Fort Mill, S.C.

How does Flyte enhance the private aviation experience?

Flyte modernizes private aviation through a technology-enabled booking platform, strategic partnerships, and a focus on exceptional service.

Who founded The Nucleus Network?

The Nucleus Network was founded by entrepreneurs Michael Axman and Jake Fleshner to create connections within the startup ecosystem.

What aircraft does Flyte operate for its services?

Flyte operates a growing fleet of Cirrus Vision Jets for efficient short-haul private travel throughout the United States.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.


Full Release

Strategic Partnership Places Flyte at the Center of One of the Nation's Premier Communities of Founders, Investors, and Operators

Collaboration Reflects Flyte's Continued Commitment to Building Relationships Within the Entrepreneurial and Venture Capital Ecosystem

FORT MILL, S.C., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Flyte, a subsidiary of Catheter Precision, Inc. (NYSE American: VTAK) ("VTAK" or the "Company"), today announced a strategic partnership with The Nucleus Network, a rapidly growing community connecting founders, investors, executives, and innovators, to support the inaugural "The Nucleus" event taking place August 15th at 4:00 p.m.

As an official partner, Flyte will participate in the launch of what The Nucleus Network intends to become its signature annual gathering, bringing together approximately 200 of its closest founders, investors, operators, and strategic partners for an exclusive evening of networking, curated brand activations, exceptional hospitality, and collaborative relationship building.

Founded by entrepreneurs and investors, The Nucleus Network has grown into an ecosystem focused on creating meaningful connections across the startup community through its venture, advisory, and community initiatives.

"Our mission has always been to build relationships with the people and communities shaping the future of business," said Marc Sellouk, Founder and CEO of Flyte. "The Nucleus Network has created an incredible ecosystem of founders, investors, and operators, and we're excited to partner on what we believe will become one of the premier annual gatherings for this community. We look forward to supporting the event while introducing Flyte to an audience that values innovation, entrepreneurship, and meaningful connections."

The partnership represents another step in Flyte's strategy of aligning with influential organizations and communities that bring together business leaders, investors, entrepreneurs, and innovators. As Flyte continues expanding its presence through strategic partnerships, the Company remains focused on becoming the preferred private aviation provider for individuals and organizations that value efficiency, exceptional service, and premium travel experiences.

Flyte operates a growing fleet of Cirrus Vision Jets and provides efficient short-haul private aviation throughout the Northeast and beyond. Through its technology-enabled booking platform, strategic partnerships, and expanding network, Flyte continues to modernize the private aviation experience while building relationships with leading brands and communities across hospitality, sports, lifestyle, and business.

About Flyte

Flyte is a private aviation company operating a growing fleet of Cirrus Vision Jets and providing efficient short-haul private travel throughout the United States. Through its technology-enabled booking platform, standardized pricing on select routes, and growing network of strategic partners, Flyte delivers a faster, safer, and more convenient alternative to traditional private aviation.

Flight operations are conducted through Flyte's wholly owned subsidiary, Ponderosa Air, LLC, an FAA-certified Part 135 air carrier.

For more information, visit www.flyflyte.com .

About The Nucleus Network

The Nucleus Network is a community of founders, investors, executives, and innovators dedicated to creating meaningful connections across the startup ecosystem. Founded by Michael Axman and Jake Fleshner, the organization operates through its venture, advisory, and community initiatives while hosting curated events that bring together entrepreneurs and investors to foster collaboration, business growth, and long-term relationships.

About Catheter Precision

Catheter Precision is an innovative U.S.-based medical device company developing advanced solutions to improve the treatment of cardiac arrhythmias. The company focuses on bringing new technologies to market through collaboration with physicians and continuous product innovation.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements preceded by, followed by or that otherwise include the words "believe," "anticipate," "estimate," "expect," "intend," "plan," "potential," "project," "prospects," "outlook," and similar expressions are forward-looking in nature and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Readers are encouraged to review the Company's filings with the SEC, including its Forms 10-K and Forms 10-Q, for additional information regarding these risks.

Contact
Investor Relations
IR@catheterprecision.com


Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Catheter Precision, Inc. (VTAK)